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High glucose augments angiotensin II action by inhibiting NO synthe-
sis in in vitro microperfused rabbit afferent arterioles. Preglomerular
afferent arteriole (Af-Art) is a crucial vascular segment in the control of
glomerular hemodynamics. We have recently reported that vascular
reactivity of Af-Art is modulated by nitric oxide (NO). However, little is
known about its reactivity under pathophysiological conditions such as
diabetes, which is often accompanied by abnormal glomerular hemody-
namics. In the present study, we examined the direct effects of high
glucose, the hallmark of diabetes, on the vascular reactivity of Af-Art.
Rabbit Af-Arts were microperfused for three hours with medium 199
containing either normal (5.5 mM; NG-Af-Arts) or high concentrations
(30 mM; HG30-Af-Arts) of glucose, and then vascular reactivity was
examined. Sensitivity to angiotensin II (Ang II) was significantly higher in
HG30-Af-Arts than in NG-Af-Arts. Ang II began to cause significant
constriction from iO M in NG-Af-Arts (18 3%, N = 6, P < 0.01) and
from 1011 M in HG30-Af-Arts (9 2%, N = 6, P < 0.01). NO synthesis
inhibition with iO M nitro-L-arginine methyl ester (L-NAME) increased
the sensitivity to Ang II in NG-Af-Arts without affecting Ang II action in
HG30-Af-Arts. In L-NAME-pretreated NG-Af-Arts, Ang II began to
cause constriction from lO M (11 3%, N = 6, P < 0.01). Thus,
pretreatment with L-NAME abolished the difference in sensitivity to Ang
II between NG- and HG30-Af-Arts, suggesting impaired NO synthesis in
HG30-Af-Arts. Indeed, 10 M of acetyicholine, which cause vasodilation
through NO, dilated preconstricted NG-Af-Arts by 79 12% (N = 6)but
only by 16 4% (N = 7) in HG30-Af-Arts. These results suggest that
abnormal glomerular hemodynamics which accompany diabetes are due,
at least in part, to the impaired modulatory role of NO in the vascular
reactivity of Af-Art.
The early stages of both clinical and experimental diabetes
mellitus are characterized by abnormal glomerular hemodynamics
(glomerular hyperperfusion and glomerular hypertension) which
cause glomerular hyperfiltration [1—5]. This glomerular hyperfil-
tration is now believed to participate in the pathogenesis of
diabetic nephropathy in accelerating glomerular injury [4, 6, 7].
Thus, it is important to understand the mechanisms responsible
for diabetes-induced abnormal glomerular hemodynamics. In-
creases in glucose, insulin, glucagon, growth hormone, atrial
natriuretic peptide (ANP), prostaglandins (PGs) as well as activity
of the renin-angiotensin system have been implicated in the
etiology of glomerular hyperfiltration [8]. Ortola et al [9] have
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reported that in diabetic rats increased plasma levels of ANP may
mediate glomerular hyperfiltration, since ANP antiserum uni-
formly reduced the glomerular filtration rate (GFR) toward
normal. Contribution of increased production of vasodilatory PGs
to altered glomerular hemodynamics with diabetes has also been
suggested in both in vivo [31 and in vitro [10]. However, direct
effects of high glucose, the hallmark of diabetes, on the glomer-
ular hemodynamics are not fully understood. Since the afferent
arteriole (Af-Art) accounts for most of preglomerular resistance
and plays a major role in the control of glomerular hemodynam-
ics, it is important to understand the direct effect of high glucose
on this vascular segment.
The purpose of the present study was to examine the direct
effects of high glucose on Af-Art in the absence of confounding
systemic hemodynamic (such as volume expansion) and neuro-
hormonal (such as ANP or insulin) influences. For this, we
microdissected and perfused rabbit Af-Arts in vitro and studied
whether or not high glucose affects the vascular reactivity of
Af-Arts to angiotensin II (Ang II), which is modulated by locally
produced nitric oxide (NO) [111.
Methods
Isolation and micropeifusion of the rabbit Af-Art
We used methods similar to those described previously to
isolate and microperfuse Af-Arts [11—13]. Briefly, a single super-
ficial Af-Art with its glomerulus (including Bowman's capsule but
not macula densa) intact was microdissected from the kidney of
each young male New Zealand white rabbit (1.5 to 2.0 kg body wt)
and transferred to a temperature-regulated chamber mounted on
an inverted microscope (IMT-2; Olympus, Tokyo, Japan). The
Af-Art was then cannulated with an array of glass pipettes and
perfused at 60 mm Hg with oxygenated medium 199 (Gibco,
Grand Island, NY, USA) containing 5% BSA (Sigma, St. Louis,
MO, USA). The bath was identical to the arteriolar perfusate
except that it contained 0.1% BSA, and was exchanged continu-
ously. Microdissection and cannulation of the arteriole were
completed within 90 minutes at 8°C, after which the bath was
gradually warmed to 37°C for the rest of the experiment. Once the
temperature was stable, a 30-minute equilibration period was
allowed before taking any measurements.
After the equilibration period, Af-Arts were divided into the
following three groups: (a) normal glucose-treated Af-Art (NG-
Af-Art) had an unchanged perfusate and bath (containing 5.5 mM
glucose); (b) high glucose-treated Af-Art (HG-Af-Art), 9.5 mM or
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24.5 mri D-glucose (Sigma) was supplemented to both perfusate
and bath to increase the glucose concentration to 15 (HG15-Af-
Art) or 30 mM (HG30-Af-Art); or (c) osmotic control Af-Art, 24.5
mM mannitol (Sigma) was supplemented to both perfusate and
bath to adjust the osmolarity.
Images of the arteriole were displayed at magnifications up to
X 1,980 and recorded with a video system consisting of a camera
(CS52OMD; Olympus), monitor (PVM1445MD; Sony, Tokyo,
Japan) and video recorder (HR-S101; Victor, Tokyo, Japan). The
diameter at the most responsive point (which was located at a
segment within 50 sm of the glomerulus) was measured with a
video micro meter (VM-30; Olympus).
Experimental protocols
Effect of high glucose on the luminal diameter of Af-Arts. After
the 30-minute equilibration period, Al-Arts were exposed to
normal or high concentration (15 or 30 mM) of glucose for three
hours. Luminal diameter was observed for three hours and
measured hourly. The three hour exposure period was selected
because Gupta et al [141 reported that exposure to high glucose
(22 or 44 mM) for three hours significantly decreases rabbit aortic
Na,K-ATPase activity to a similar extent to that seen in
diabetes.
Effect of high glucose on Ang II action in Af-Arts. Alter three
hours of exposure to normal or high glucose (15 or 30 mM),
increasing doses of Ang 11(10_li to 10_8 Sigma) were added
to the bath. Luminal diameter was measured immediately before
adding Ang II and observed for at least three minutes at each
dose.
Effect of high glucose on NO synthesis inhibition in Af-Arts. We
found that exposure to high glucose causes constriction and
augmentation of Ang II action in Af-Arts (Results). These effects
were similar to those observed when NO synthesis was inhibited
by nitro-L-arginine methyl ester (L-NAME) [11], a NO synthesis
inhibitor [15]. Thus, we tested the hypothesis that high glucose
inhibits basal NO synthesis in Af-Arts. After three hours of
exposure to normal or high glucose (30 mM), increasing doses of
L-NAME (10—v to iO Sigma) were added to the perfusate.
The luminal diameter was measured immediately before adding
L-NAME and observed for at least 15 minutes at each dose.
Effect of high glucose on Ang II action in Af-Arts pretreated with
L-NAME. To test the hypothesis that high glucose augments Ang
II action by inhibiting NO synthesis in Al-Arts, we examined
whether the effects of high glucose and NO synthesis inhibition on
Ang II action are additive. Alter a three hour exposure to normal
or high glucose (30 mM), L-NAME at iO M was added to the
perfusate. Fifteen minutes later, the effects of Ang II were
examined as in protocol 2 and the results were compared with
those of protocol 2. We have previously shown that L-NAME at
this concentration blocks acetyicholine (Ach)-induced vasodila-
tion in Af-Arts [16].
Effect of L-arginine (L-Aig) on high glucose-induced constriction
and augmentation of Ang II action in Af-Arts. To study whether the
effect of high glucose is mediated by basal NO synthesis inhibition,
we next examined whether L-Arg, a precursor of NO, abolishes
high glucose-induced constriction and augmentation of Ang II
action in Al-Arts. Alter the equilibration period, L-Arg (Sigma) at
i0 M was added to the perfusate. Fifteen minutes later, in the
presence of L-Arg, the effects of high glucose (30 mM) on the
luminal diameter and Ang II action were examined. We have
previously demonstrated that this dose of L-Arg reverses the
effects of L-NAME (10—a M) in rabbit Al-Arts [11]
Effect of high glucose on Ach-induced vasodilation in Af-Arts. To
further study whether high glucose really impairs NO synthesis in
Al-Arts, we examined the effects of Ach, which cause vasodilation
through NO. Since isolated Af-Art has little intrinsic tone, making
it difficult to observe its dilator response, dilator actions of Ach
were examined with preconstricted Al-Arts. Alter the equilibra-
tion period, Al-Arts were preconstricted by about 45% with
norepinephrine (NE, Sigma) at 0.5 M added to the bath, after
which Al-Arts were exposed to normal or high glucose (30 mM)
for three hours. Then 10_6 or i0 M of Ach (Sigma) were added
to the perfusate. The luminal diameter was measured immediately
before adding Ach and observed for at least 10 minutes at each
dose. In this protocol, NE was used to preconstrict Al-Arts
because vasoconstrictor action of NE is not modulated by NO in
rabbit Al-Arts [111.
Data analysis
Values were expressed as mean SEM. All statistical analyses
were done using percent changes from the control level (protocol
1) or from the pre-treated level (protocols 2 and 3, normal or high
glucose-treated levels; protocol 4, L-NAME-treated level; proto-
col 5, L-Arg-treated level or high glucose-treated level; protocol 6,
normal or high glucose-treated level or washout level). Paired
t-tests were used to examine whether the diameter at a given
concentration differed from the control (protocol 1) or pre-
treated (protocol 2 to 6) value within each group. When more
than one comparison was made, Bonferroni's multiple compari-
son adjustment was used to reduce the significance level of each
paired t-test from 0.05 to 0.017 (0.05/3; Bonferroni's adjustment
for 3 time levels) in protocols 1 and 5, to 0.0125 (0.05/4; for 4 dose
levels) in protocol 2 to 5 or to 0.025 (0.05/2; for 2 dose levels) in
protocol 6 (response to Ach). A two-sided Student's t-test (or
Welch's test if variances were unequal) was used to examine
whether the change in diameter at a given concentration differed
between two groups. For this analysis, P < 0.05 was considered
significant (Bonferroni's adjustment was not used).
Results
Effect of high glucose on the luminal diameter of Af-Arts (Fig. 1).
Basal luminal diameter of NG-, HG15- or HG30-Al-Arts was not
different, with a mean value of 17.3 0.5 m (N = 7), 18.0 0.6
p.m (N 7) or 17.6 0.3 p.m (N = 16), respectively. Exposure to
high glucose caused a dose- and time-dependent constriction, and
a significant constriction was observed at one hour in HG10-Af-
Arts (by 9 2% to 16.1 0.4 p.m, P < 0.01) and at two hours in
HG15-Al-Arts (by 11 2% to 16.0 0.4 p.m,P < 0.015). At three
hours, the luminal diameter decreased by 12.3 2.6% to 15.7
0.3 p.m in HG15-Al-Arts and by 15.6 1.4% to 14.8 0.3 p.m in
HG30-Al-Arts. No change was observed in the luminal diameter
of Al-Arts exposed to normal glucose (16.8 0.6 p.m at 3 hr). In
addition, increase in osmolarity by mannitol had no effect (N =5)
on the luminal diameter of Al-Arts, suggesting that high glucose-
induced constriction was not due to hyperosmolarity.
Effect of high glucose on Ang II action in Af-Arts. Alter three
hours of exposure, the luminal diameter changed from 17.3 0.5
to 16.7 0.7 p.m in NG-Al-Arts (N = 6), from 17.7 0.5 to 15.8
0.5 p.m in HG15-Al-Arts (N = 6) and from 17.2 0.5 to 14.8
0.7 p.m in HG30-Al-Arts (N = 6). As shown in Figure 2, Ang II
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Fig. 1. Effect of high glucose on the luminal
diameter of Af-Arts. Luminal diameters are
expressed as absolute value (A) or percent of
basal diameter (B). Exposure to high glucose
caused dose- and time-dependent constriction;
significant constriction was observed at two
hours in Al-Arts treated with 15 m glucose
(U, 11 2%, N = 7) or at one hour in Al-Arts
treated with 30 m glucose (S, 9 2%, N =
16). No change was observed in Al-Arts
exposed to normal glucose (0, N = 7). In
addition, increase in osmolarity by mannitol
had no effect on the luminal diameter of Al-
Arts (0, N = 5) * < 0.015, **p < 0.01
versus basal diameter. Abbreviation is Al-Art,
afferent arteriole.
0.5 to 16.5 0.3 .tm in NG-Af-Arts (N = 6) and from 17.9
0.6 to 15.1 0.5 m in HG30-Al-Arts (N = 7). In NG-Af-Arts,
L-NAME caused dose-dependent constriction, with the decrease
in diameter becoming 2.0 0.5 rm or 12.0 2.9% at io M (P <
0.01) and 3.6 0.6 m or 21.9 3.3% at iO M. Increase in
osmolarity by mannitol did not affect L-NAME action (N = 4). In
contrast, L-NAME had only a minor effect on HG30-Af-Arts;
L-NAME had no effect on HG30-Af-Arts until the concentration
reached io— M, which decreased the diameter only by 1.3 0.3
tm or 8.3 2.1% (P < 0.012). Thus, the effect of L-NAME was
significantly (P < 0.01) weaker in HG30-Af-Arts than in NG-Af-
Arts, suggesting that an increase in extracellular glucose concen-
0 —11 —10 —9 —8 tration impairs basal NO synthesis in Al-Arts.
Effect of high glucose on Ang II action in Af-Arts pretreated with
L-NAME. After a three hour exposure, the luminal diameter
changed from 17.3 0.4 to 16.7 0.3 m in NG-Af-Arts (N = 6)
and from 17.9 0.7 to 15.0 0.6 m in HG30-Al-Arts (N = 6).
L-NAME at iO M decreased the diameter to 13.0 0.4 .Lm in
NG-Af-Arts and to 13.7 0.5 m in HG30-Af-Arts, which were
not different from each other. As shown in Figure 3, L-NAME
pretreatment significantly augmented Ang II action in NG-Af-
Arts; Ang II now began to cause significant constriction from
10_li M (by 1.5 0.5 .tm or 11.4 3.3%, P < 0.01). Compared
to non-treated NG-Af-Arts, Ang If-induced vasoconstriction was
stronger in L-NAME-treated NG-Af-Arts at doses of 10_si,
10_b and but not 10_8 M. Increase in osmolarity by
mannitol had no effect on L-NAME-induced augmentation of
Ang II action in Al-Arts (N = 4). In contrast, L-NAME had no
effect on Ang II action in Al-Arts already treated with high
glucose (30 mM). Thus, the effects of high glucose and NO
synthesis inhibition on Ang II action were not additive. Figure 4
compares the effects of L-NAME pretreatment and high glucose
(30 mM) treatment on Ang II action in Al-Arts. Exposure to high
glucose had same effects with L-NAME pretreatment on Mg II
action in Al-Arts, suggesting that an increase in extracellular
glucose concentration augments Ang II action by inhibiting NO
synthesis in Al-Arts.
Effect of L-Arg on high glucose-induced constriction and auginen-
tation of Ang II action in Af-Arts (Fig. 5). L-Arg at i0 M
increased the luminal diameter of Al-Arts from 17.9 0.3 to 18.5
0.2 j.m (N = 4). In L-Arg-pretreated Al-Arts, exposure to high
glucose (30 mM) for three hours did not affect the luminal
diameter (18.6 0.3 m at 3 hr). In addition, pretreatment with
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Fig. 2. Effect of high glucose on Ang II action in Af-Arts. Luminal
diameters are expressed as percent of pre-Ang II value (diameter at 3 hr
exposure). In normal glucose-treated Al-Art (0, N = 6), Ang II began to
cause constriction from io M (18 3%). Increase in osmolarity by
mannitol had no effect on Ang II action in Al-Arts (0, N = 5). Exposure
to high glucose for three hours significantly augmented Ang II action in
Al-Arts. In high glucose treated-Al-Arts, Ang II began to cause constric-
tion from 10_b M (15 m U; 12 4%, N = 6) or from i0" M (30 mvi
•; 9 2%, N = 6). **P < 0.01 versus pre-Ang II value. Abbreviations are:
Ang II, angiotensin II; Al-Art, afferent arteriole.
had no effect on NG-Al-Arts until the concentration reached
iO M, which decreased the diameter by 3.1 0.5 m or 17.9
2.7% (P < 0.001). Exposure to high glucose for three hours
significantly augmented Mg II action in Al-Arts. In HG15- or
HG30-Af-Arts, Ang II began to cause constriction from 10_b M
(by 1.8 0.6 tm or 11.8 3.7%; P < 0.01) or from io M (by
1.4 0.2 m or 9.4 1.8%; P < 0.01), respectively. Compared to
NG-Al-Arts, Mg Il-induced constriction was stronger in HG30-
Af-Arts at doses of 10_li to i0 M. In osmotic control Al-Arts
(N = 5), no alteration was observed in Mg II action compared
with that in NG-Af-Arts, suggesting that high glucose-induced
augmentation of Ang II action was not due to hyperosmolarity.
In addition, this augmentation was not due to increase in
vascular tone induced by decrease in basal diameter, since we
have previously reported that NE-induced decrease in basal
diameter (by about 16%) does not affect Ang II action in rabbit
Af-Arts [11].
Effect of high glucose on NO synthesis inhibition in Af-Arts. After
three hours of exposure, the luminal diameter changed from 17.1
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B Fig. 3. Effect of L-NAME on Ang II action in Af-
Arts treated with normal (A) or high concentration
(30 mM) of glucose (B). Luminal diameters are
expressed as percent of pre-Ang II value. In
normal (5.5 mM) glucose-treated Af-Art, L-NAME
(10 M) significantly augmented Ang H action at
doses of 10" to i0 M; Ang II at 10_it M, which
had no effect on Af-Arts without L-NAME
pretreatment, caused significant constriction by 11
3% (N = 6). In contrast, L-NAME had no effect
on Ang H action in Al-Arts already treated with
high glucose (30 mi, N = 6). Symbols are:
0.01 versus pre-Ang II value; ##p < 0.01 non-
versus L-NAME-treated arterioles; (0) non-treated
Al-Arts; (•) L-NAME-treated Al-Arts.
0 —ii —10 —9 —8 Abbreviations are: L-NAME, nitro-L-arginine
methyl ester Ang Il, angiotensin II Al-Art
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Fig. 4. Effect of L-NAME or high glucose on Ang II action in Af-Arts. This
Figure compares the effects of L-NAME (l0 M) pretreatment and high
glucose (30 mM) treatment on Ang II action in Al-Arts. High glucose
treatment had same effects with L-NAME pretreatment on Ang II action
in Al-Arts. Symbols are: < 0.01 versus pre-Ang II value; ##] < 0.01
versus NG-Af-Arts; (0) NG-Af-Arts (N = 6); (LI) L-NAME-treated
NG-Af-Art (N = 6); (•) HG39-Af-Arts (N = 6). Abbreviations are:
L-NAME, nitro-L-arginine methyl ester; Ang II, angiotensin II; Al-Art,
afferent arteriole.
Ang II action in AS-Arts. In L-Arg-pretreated HG30-Af-Arts, Ang II
at 10 or 10'° M did not cause significant constriction, and at 10
or 10 M the diameter decreased by 15.3 2.2% (P < 0.01) or 49.4
3.8% (P < 0.001). There was no difference in Ang II action
between NG-Af-Arts and L-Arg-pretreated HG30-Af-Arts, again
strongly suggesting that the effect of high glucose on Af-Arts is
mediated by basal NO synthesis inhibition.
Effect of high glucose on Ach-induced vasodilation in Af-Arts (Fig.
6). Basal luminal diameter of NG- or HG30-Af-Arts was not
different, with a mean value of 17.7 0.6 tm (N 6) and 18.3
0.2 tm (N = 7), respectively, and NE at 0.5 jrM similarly
decreased the luminal diameter by about 45%. After three hours
of exposure to normal or high glucose, the luminal diameter
changed from 10.0 0.6 to 10.1 0.8 jm in NG-Af-Arts and
from 10.0 0.4 to 10.9 0.3 m in HG30-Af-Arts. Ach at 10_6
M dilated NE-treated NG-Af-Arts by 4.3 0.7 jim or 44.9 8.2%
(P < 0.001); at i0 M, the diameter increased by 7.5 0.9 jim or
78.6 12.1%. In contrast, Ach had only a minor effect in
NE-treated HG30-Af-Arts. Ach at 10 Mdid not cause significant
dilation, and at 10 M the diameter increased only by 1.7 0.4
jim or 15.7 3.5% (P < 0.01). Thus, effects of Ach in HG30-Af-
Arts were significantly (P < 0.01) weak compared to those
observed in NG-Af-Arts. Since NO causes vasodilation by increas-
ing the content of cGMP in vascular smooth muscle cells (VSMC)
[17], we excluded the possibility that Ach did not cause strong
dilation in HG3-Af-Arts due to impaired response of VSMC to
increase in cGMP, For this, we examined the effects of sodium
nitroprusside (SNP), which directly releases NO and stimulates
guanylate cyclase by an endothelium-independent mechanism [18,
19]. After examining the effects of Ach at 10 M, arteriolar lumen
was washed out with normal or high glucose control media for 20
minutes (which returned the diameter to NE-preconstricted level)
and then io M of SNP (Sigma) was added to the perfusate. As
shown in Figure 6, SNP had similar effects on both Al-Arts; in
both Af-Arts SNP at iO M increased the diameter to the level
which was not different from basal value (18.4 0.8 jim in
NG-Af-Arts or 18.9 0.3 jim in HG30-Af-Arts).
Discussion
The early stages of diabetes mellitus are characterized by
glomerular hyperperfusion which contributes to the pathogenesis
of diabetic glomerulopathy 4, 6, 7]. The principal determinant of
this deleterious increase in glomerular perfusion is a reduction in
preglomerular vascular resistance, which is mainly regulated by
Af-Art. One factor which may alter afferent arteriolar resistance is
the increase in extracellular glucose concentration per Se. Indeed,
control of blood glucose levels in diabetes with insulin often
returns elevated GFR toward normal [20, 21]. However, it has
been difficult to establish the mechanisms by which increase in
extracellular glucose concentration affects the vascular tone of
Al-Art. With the development of techniques that permit direct
visualization of this arteriole, it has now become possible to study
the direct effects of increase in extracellular glucose concentration
on Af-Arts. In the present study, we found that increase in
extracellular glucose concentration in Af-Arts in vitro: (1) caused
constriction rather than dilation; (2) augmented Ang II action but
attenuated the effect of NO synthesis inhibition; and (3) inhibited
the effect of Ach but not SNP. We also found that effects of high
glucose were abolished by pretreatment with L-Arg, a precursor
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Fig. 5. Effect of L-Arg on high glucose-induced
constriction (A) and augmentation of Ang II action
(B) in Af-Arts. Luminal diameters are expressed
as absolute value (A) or percent of pre-Ang II
value (diameter at 3 hr exposure) (B).
Pretreatment with L-Arg (10 M) abolished the
high glucose (30 mM)-induced constriction (A)
and augmentation of Ang II action (B) in Af-
Arts. In L-Arg-pretreated At-Arts, exposure to
high glucose for three hours did not affect
luminal diameter. There was no difference in Ang
H action between NG-Af-Arts and L-Arg-
pretreated HG30-Af-Arts. Symbols are: **p <
0.01 versus basal diameter; ** < 0.01 versus
pre-Ang II value; ##p < 0.01 versus NG-Af-Arts;
(0) NG-Af-Arts; (S) HG30-Af-Arts; () L-Arg-
pretreated HG30-Af-Arts. Abbreviations are:
L-Arg, L-arginine; Ang II, angiotensin II; Af-Art,
afferent arteriole.
that vascular responses to NO is not altered by high glucose.
Therefore, high glucose may impair endothelium-dependent Va-
sodilation by inhibiting the synthesis or release of NO without
affecting the vascular responses to NO. This idea is also supported
by the finding of Gupta et al [14] that an increase in extracellular
glucose decreases basal release of NO from rabbit aorta.
Abnormalities of vascular reactivity are well known to occur in
diabetes. Aortas from diabetic rats demonstrated decreased con-
tractile responses to Ang II [25]. With regard to the kidney, it has
been reported that the decrement in renal blood flow and GFR
that normally follows Ang II infusion was markedly blunted in
diabetic rats [26], suggesting decreased contractile response of
Af-Art to Ang II. Moreover, micropuncture studies have indi-
cated reduced basal vascular tone of Af-Art in diabetes [2—5].
Taken together, most studies have indicated that both basal tone
and response to Ang II of Af-Art are markedly decreased in
diabetes. However, in the present study an increase in extracellu-
lar glucose constricted Af-Art and augmented Ang II action in it.
Although the reason for this discrepancy is unclear, there are
several possibilities. First, since we used isolated Af-Art in vitro,
we could not observe the effects of systemic hormones (such as
ANP) or tubuloglomerular feedback (TGF), which contribute to
glomerular hemodynamics in vivo. It has been postulated that an
increase in extracellular volume caused by diabetes results in the
release of ANP, which dilates Af-Art [27] and would counteract
vasoconstrictors. Indeed, Ortola et al [9] have reported that
plasma levels of ANP are increased in diabetic rats, and have
provided evidence that this increased ANP contributes to the
glomerular hyperfiltration since ANP antiserum uniformly re-
duced GFR toward normal. In addition, impaired TGF may be
responsible for the abnormal glomerular hemodynamics in diabe-
tes. Woods et al [28] have reported that hyperglycemia-induced
increase in GFR is due to impaired TGF. In accordance with their
reports, Blantz et al [29] have also shown that hyperglycemia
impairs single nephron TGF. Secondly, high glucose-induced
down-regulation of pressor receptors may be relevant to abnormal
responses of Af-Arts in diabetes. Williams, Tsai and Schrier [30]
have recently reported that exposing the VSMC to high glucose
(20 mM) resulted in a significant decrease in Ang II binding to
VSMC due to a decline in surface density of its receptor. In that
study they also examined the time dependency of Aug II receptor
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Fig. 6. Effect of high glucose on Ach-induced vasodilation in Af-Art.
Luminal diameters are expressed as absolute value. Exposure to high
glucose (30 mM) for three hours significantly attenuated Ach-induced
vasodilation in At-Arts. Ach at iO M dilated normal glucose-treated
Af-Arts by 79 12% but only by 16 4% in high glucose-treated Af-Arts.
However, there was no difference in the action of SNP (10 M) between
these arterioles. Symbols are: * *p < 0.01 NG-Af-Art versus HG30-Af-
Arts; (0) NG-Af-Arts (N = 6); (•) HG30-Af-Arts (N = 7). Abbreviations
are: Ach, acetyicholine; At-Art, afferent arteriole; SNP, sodium
nitroprusside.
NO synthesis which in turn causes constriction and augmentation
of Ang II action in At-Art, since endogenous NO controls basal
tone and counteracts Ang II action in the Af-Art [11]. These
results may be consistent with the findings of Ohishi and Carmines
[221 that NO activity is decreased in rat AS-Arts during the
hyperfiltration stage of diabetes.
In agreement with our results, several studies have reported
impaired endothelium-dependent vascular relaxation by high glu-
cose [23, 24]. Tesfamariam, Brown and Cohen [24] have reported
that exposure to high glucose (22 or 44 mM) for six hours
significantly decreased Ach-induced relaxation in rabbit aorta.
However, the mode by which high glucose impairs endothelium-
dependent vasodilation was unclear. In the present study, an
increase in extracellular glucose significantly attenuated Ach- but
not SNP-induced vasodilation in At-Art. Since SNP causes vaso-
dilation through directly releasing NO [18, 191, this would suggest
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to high glucose was required for significant down-regulation.
Thus, although the decrease in Ang IT-induced contraction in
diabetes could due partly to glucose-induced receptor down-
regulation, significant down-regulation of Ang II receptor in
Af-Art did not occur in the present study since we exposed Af-Art
to high glucose only for three hours. Third, it has been reported
that exposure to high glucose (20 mM) for more than 12 hours also
decreases the basal Ca2 uptake by VSMC [31]. Thus, in diabetes,
afferent arteriolar tone may be decreased due to depression in
Ca2 influx into VSMC. However, this effect could not be
observed in the present study either. Thus, without a long
exposure which also causes systemic hormonal alterations, high
glucose may not dilate but rather it may constrict Af-Art. In
agreement with this idea, dilation of small intrarenal arteries and
arterioles was morphologically established in spontaneously dia-
betic KK-mice at 12 months of age, whereas at two months the
diabetic arteries and arterioles were smaller than controls [32]. In
addition, our results also may be consistent with the reports of
Walczyk, Pulliam and Bennett [33] that hyperglycemia caused
renal vasoconstriction in normal (not diabetic) humans.
The observation that L-Arg (at io— M) abolished the high
glucose-induced constriction and augmentation of Ang II action
in Af-Arts raises two possibilities: first, high glucose may decrease
the affinity of NO synthase for L-Arg; or second, high glucose
could diminish NO synthesis by causing arginine depletion. How-
ever, the latter is unlikely because the medium (medium 199) used
for bath and perfusate contains L-Arg at 0.33 X iO M (thus, this
dose of L-Arg was continuously supplied to both the bath and
perfusate). Regarding the possibility of decreased affinity of NO
synthase for L-Arg, high glucose-induced protein kinase C (PKC)
activation may be involved. It has been demonstrated that an
increase in extracellular glucose concentration increases PKC
activity in vivo and in many cell types (including VSMC) in vitro
[34—381, and that PKC activation inhibits NO synthesis [39, 40].
Thus, one possible explanation for our findings is that high
glucose, by increasing PKC activity, inhibits the synthesis (or
release) of NO which in turn causes constriction and augmenta-
tion of Ang II action in Af-Art. In support of this idea, Tes-
famariam, Brown and Cohen [24] reported that an increase in
extracellular glucose concentration impairs endothelium-depen-
dent relaxation in rabbit aorta by activating PKC. However,
further studies are needed to confirm this possibility.
In the present study, an increase in extracellular glucose caused
constriction in non-preconstricted Af-Arts but not in precon-
stricted Af-Arts. The reason why high glucose did not constrict
preconstricted Af-Arts was unclear. However, overproduction of
vasodilatory PGs may be involved. Several studies have reported
that increase in extracellular glucose stimulates the production of
vasodilatory PGs in the kidney [38, 411, which may modulate the
Af-Art tone when it is elevated. This idea maybe supported by the
findings of Hayashi et al [10], who found that pressure-induced
vasoconstriction (myogenic response) of Al-Art was markedly
diminished in diabetic rats, and that this impairment was signifi-
cantly restored by inhibiting PG synthesis or by normalization of
blood glucose level with insulin. In addition, in that study PG
synthesis inhibition had no effect on the basal diameter of Af-Art.
These results suggest that high glucose stimulates the production
of PGs which modulate Af-Art tone only when it is elevated.
However, since Ang II itself stimulates PG synthesis in the kidney
[42], high glucose-induced PG release may not affect increased
AS-Art tone-induced by Ang II.
In summary, we provide evidence that high glucose inhibits
basal NO synthesis in Al-Art in vitro. We show that treatment of
AS-Art with high concentration of glucose for three hours caused
constriction and augmentation of Ang II action to a similar extent
to that observed when NO synthesis was inhibited. We have also
shown that high glucose significantly inhibited the vasodilatory
effects of Ach but not SNP in AS-Art. Although it is impossible to
extrapolate directly from in vitro data to an in vivo situation, if an
increase in extracellular glucose concentration inhibits basal NO
synthesis in Af-Art in vivo, then abnormal glomerular hemody-
namics associated with diabetes is due, at least in part, to the
impaired modulatory role of NO in the vascular reactivity of
Al-Art. In addition, chronic inhibition of renal NO synthesis
causes renal dysfunction and systemic hypertension [431. Thus,
progression of renal dysfunction and high incidence of systemic
hypertension in diabetes (especially type II diabetes) may be due
partially to an inhibition of NO synthesis in AS-Arts induced by
high glucose.
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